
A vascular surgeon spent years making high-stakes decisions one patient at a time. Now he is building Doctronic around a harder question: how much good judgment can software deliver when the waiting room has no walls?
Prana is a San Francisco startup building a 24/7 AI doctor that watches your health data between checkups. It pulls your medical records and wearable data into one clinical timeline, watches for early warning signs the company calls 'clinical drift' - rising blood pressure or glucose weeks before a crisis - and lets you chat with its AI for free or see a real physician for a flat $39 visit. Founded by Meer Patel, Vishvam Rawal, and Sanjit Menon, Prana launched out of Y Combinator's Winter 2026 batch.
Doctronic is a New York-based health technology company building an AI-native primary care platform. Its free, anonymous AI doctor gives instant symptom assessments and treatment guidance grounded in peer-reviewed research, and connects patients to licensed physicians for $39 video visits or an insurance copay. Founded in 2023 by technologist Matt Pavelle and vascular surgeon Dr. Adam Oskowitz, the company has processed more than 15 million medical conversations, became the first AI to legally renew prescriptions in the U.S. under Utah's regulatory sandbox, and has raised $65 million across three rounds in under a year.
GenieMD is a San Ramon, California virtual care company that sells a single, white-label platform folding together telehealth, remote patient monitoring, remote therapeutic monitoring and chronic care management - plus built-in e-prescriptions, lab integration and CPT billing reports. Founded in 2010 by Stanford-trained engineer Soheil Saadat, it sells to hospitals, health systems, group practices, insurers, ACOs and employers, and in 2026 launched HelloGenie, a free AI doctor that hands patients off to real board-certified physicians when actual care is needed. Frost & Sullivan named it 2024 Company of the Year for virtual chronic disease management.
Nicolas Abad is the co-founder and CEO of Telepatia, a Latin American healthtech company building AI healthcare workers - starting with an 'AI Doctor' that transcribes consultations, reviews records, flags drug interactions, and surfaces clinical guidance in real time. Named after his late father's nickname, the company grew from a Stanford MBA side obsession to a venture backed by Andreessen Horowitz, reaching more than 14 million patients across five countries inside its first year. Abad's stated ambition is audacious to the point of comedy: win Latin America's first Nobel Prize in Medicine since 1984 by turning healthcare from scarcity into abundance.